Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of a New Cognitive Behavioral Therapy (CBT) to Reduce Psychological Distress and Improve Quality of Life of People With Alzheimer's Disease and Their Caregivers

NCT03656159 is registered in ClinicalTrials.gov with Dr Sébastien Grenier as lead sponsor.

NCT NCT03656159
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03656159 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of a New Cognitive Behavioral Therapy (CBT) to Reduce Psychological Distress and Improve Quality of Life of People With Alzheimer's Disease and Their Caregivers
Lead sponsor
Dr Sébastien Grenier
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2017
Completion date
June 30, 2019
Enrollment
46 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease